Human peripheral blood leukocyte engraftment into SCID mice: Critical role of CD4+ T cells

Cellular Immunology

Volumn 211, Issue 1, 2001, Pages 8-20

  Duchosal, Michel A ^a   Mauray, Sandrine ^a   Rüegg, Marlies ^a   Trouillet, Philippe ^a   Vallet, Véronique ^a   Aarden, Lucien ^b   Tissot, Jean Daniel ^c   Schapira, Marc ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Blood Transfusion Service of the Swiss Red Cross   (Switzerland)

Author keywords

Human peripheral blood leukocytes; SCID mouse; T cells; Xenotransplantation

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 6; OKT 3;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; XENOTRANSPLANTATION;

ANIMALIA;

EID: 0035838271     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2001.1822     Document Type: Article

References (56)

1. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect
2. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation
3. A severe combined immunodeficiency mutation in the mouse
4. Transfer of a functional human immune system to mice with severe combined immunodeficiency
5. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries
6. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies
7. Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells
8. Epstein-Barr virus infection and immunoregulation in man
9. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts
10. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation
11. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice
12. Properties of tumors arising in SCID mice injected with PBMC from EBV-positive donors
13. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes
14. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes
15. Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice
16. Epstein - Barr virus lymphoproliferation after bone marrow transplantation
17. + T cells
18. Human immunoglobulin production in immunodeficient mice: Enhancement by immunosuppression of host and in vitro activation of human mononuclear cells
19. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand
20. T-cell-dependent production of IgG by human cord blood B cells in reconstituted SCID mice
21. Mature helper T cell requirement for immunoglobulin production by neonatal naive B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice
22. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease
23. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model
24. The hu-PBL-SCID mouse model. Long term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice
25. Detection of cell specific cluster determinant expression by reverse transcriptase polymerase chain reaction
26. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera
27. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
28. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice
29. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice
30. Human-mouse lymphoid chimeras: Host-vs.-graft and graft-vs.-host reactions
31. Enhanced engraftment of human peripheral blood lymphocytes into anti-murine interferon-gamma monoclonal antibody-treated CB-17-scid mice
32. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice
33. The function of antigen-presenting cells in mice with severe combined immunodeficiency
34. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)
35. M1
36. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes
37. + T cell repertoire in hu-PBL-SCID chimeras
38. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes
39. Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model
40. Cytokine dependence of human to mouse graft-versus-host disease
41. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies
42. A rat monoclonal anti-(human CD2) and L-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome
43. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells
44. Epstein - Barr virus-dependent lymphoproliferative disease: Critical role of IL-6
45. The human immune system in hu-PBL-SCID mice
46. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease
47. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors
48. Production of hybridoma growth factor by human monocytes
49. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and infiuence of the atopic status on lymphoma development
50. Interleukin-6 in biology and medicine
51. Human IL-6 enhances human lymphocyte engraftment and activation but not human antibody production in SCIDhu PBL mice
52. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment
53. - cells in whole bone facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
54. Non-host-reactive donor CD8+ T cells of Tc2 phenotype potently inhibit marrow graft rejection